> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Merck
- URL: https://www.whiteroseintelligence.com/merck/
- Published: 1999-01-02T19:52:00.000Z
- Updated: 2025-02-10T01:53:43.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization

**Merck & Co., Inc.**, known outside North America as **MSD**,[\[1\]](#fn1) is an American multinational pharmaceutical company based in Kenilworth, New Jersey.[\[2\]](#fn2)

## History

In May 2002, The [Bill & Melinda Gates Foundation](https://www.whiteroseintelligence.com/Bill-&-Melinda-Gates-Foundation) purchased stock in Merck.[\[3\]](#fn3)

On August 5, 2010, Merck and the Gates Foundation announced a joint five-year $60 million contribution to the African Comprehensive HIV/AIDS Partnerships for efforts related to HIV/AIDS and tuberculosis in Botswana.[\[4\]](#fn4)

On June 29, 2016, Merck and [Moderna](https://www.whiteroseintelligence.com/Moderna) announced they were collaborating on the development of mRNA-based cancer vaccines, including work with Merck's Keytruda, an antibody-based immunotherapy drug.[\[5\]](#fn5)

### COVID-19

Near the end of March 2020, Merck joined the [COVID-19 Therapeutics Accelerator](https://www.whiteroseintelligence.com/COVID-19-Therapeutics-Accelerator) alongside a "consortium of life sciences companies."[\[6\]](#fn6)

In January 2021, [MyID](https://www.whiteroseintelligence.com/MyID) announced a partnership with Merck to "provide the MyID mobile app and wristband to patients" being treated with Merck's Keytruda.[\[7\]](#fn7)

Merck participated as a partner in the [This Is Our Shot](https://www.whiteroseintelligence.com/This-Is-Our-Shot) campaign to mass advertise [COVID-19 vaccines](https://www.whiteroseintelligence.com/COVID-19-vaccine), which launched April 28, 2021.[\[8\]](#fn8)[\[9\]](#fn9)

Merck collaborated with [Ridgeback Biotherapeutics](https://www.whiteroseintelligence.com/Ridgeback-Biotherapeutics) to develop molnupiravir, an oral mutagenic anti-viral compound, to treat COVID-19\. In October 2021, the two companies reported that data from their Phase 3 clinical trial showed molnupiravir “cuts the risk of hospitalization and death from COVID-19 by 50% in people who have mild to moderate forms of the disease.”[\[10\]](#fn10)[\[11\]](#fn11)

Merck was a sponsor for the National Community Pharmacists Association 2021 Annual Convention from October 9-12, 2021.[\[12\]](#fn12)

On November 30, 2021, the [Food and Drug Administration](https://www.whiteroseintelligence.com/Food-and-Drug-Administration) (FDA)'s Antimicrobial Drugs Advisory Committee narrowly recommended the use of molnupiravir in a 13-10 vote.[\[13\]](#fn13)

On December 3, 2021, Merck announced it had entered an agreement with the [Government of Canada](https://www.whiteroseintelligence.com/Government-of-Canada) to supply the country with up to one million "patient courses" of molnupiravir.[\[14\]](#fn14)

In January 2022, Merck and Ridgeback announced they would supply UNICEF with 3 million doses of molnupiravir through the [Access to COVID-19 Tools Accelerator](https://www.whiteroseintelligence.com/Access-to-COVID-19-Tools-Accelerator) (ACT-Accelerator) Therapeutics Partnership.[\[15\]](#fn15)

## Organization

| Name                              | Position                                                                                                                                                    | Notes                                                                                                                                                                                                                                                                                                                           |
| --------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| William Daley                     | Board Member[\[16\]](#fn16)                                                                                                                                 | JPMorgan Chase, [Third Way](https://www.whiteroseintelligence.com/Third-Way), Boeing, [Council on Foreign Relations](https://www.whiteroseintelligence.com/Council-on-Foreign-Relations)                                                                                                                                        |
| Julie Gerberding                  | Chief Patient Officer and Executive Vice President of Population Health and Sustainability (former)[\[1:1\]](#fn1)                                          | [The Commons Project](https://www.whiteroseintelligence.com/Commons-Project), [Centers for Disease Control and Prevention](https://www.whiteroseintelligence.com/Centers-for-Disease-Control-and-Prevention) (CDC)                                                                                                              |
| Richard Henriques                 | Senior Vice President of Finance for Global Human Health; Vice President and Corporate Controller; Principal Accounting Officer (all former)[\[17\]](#fn17) | [Arbutus Biopharma](https://www.whiteroseintelligence.com/Arbutus-Biopharma), University of Pennsylvania, EMulate Therapeutics, Cabaletta Bio, Franklin Institute, Heritage Conservancy, Episcopal Community Services, [Bill & Melinda Gates Foundation](https://www.whiteroseintelligence.com/Bill-&-Melinda-Gates-Foundation) |
| Fernando Pons                     | Regional Director Project Realization (former)[\[18\]](#fn18)                                                                                               | [Coalition for Epidemic Preparedness Innovations](https://www.whiteroseintelligence.com/Coalition-for-Epidemic-Preparedness-Innovations) (CEPI), ED&F Man, European Bank for Reconstruction and Development (EBRD), ExxonMobil, Rio Tinto                                                                                       |
| Walter Strapps                    | Director of RNAi Therapeutics (former)[\[19\]](#fn19)                                                                                                       | [Deep Genomics](https://www.whiteroseintelligence.com/Deep-Genomics), Liberate Bio, Carver Biosciences, Gemini Therapeutics, Intellia Therapeutics, Sirna Therapeutics, Sentigen Biosciences, Sona Nanotech                                                                                                                     |
| Princess Therese of Liechtenstein | Strategic Projects Manager (former)[\[20\]](#fn20)                                                                                                          | [Geopolitical Intelligence Services](https://www.whiteroseintelligence.com/Geopolitical-Intelligence-Services) (GIS), M Ventures                                                                                                                                                                                                |

### Subsidiaries

- EMD Serono
- M Ventures
- Merck Foundation
- Merck Global Health Innovation Fund
- Partnership for Giving (P4G)

### Partners

Merck is partnered with or a member of:

- [AcademyHealth](https://www.whiteroseintelligence.com/AcademyHealth)[\[21\]](#fn21)
- [Accelerating COVID-19 Therapeutic Interventions and Vaccines](https://www.whiteroseintelligence.com/Accelerating-COVID-19-Therapeutic-Interventions-and-Vaccines) (ACTIV)[\[22\]](#fn22)
- [Ad Standards](https://www.whiteroseintelligence.com/Ad-Standards)[\[23\]](#fn23)
- [Adult Vaccine Access Coalition](https://www.whiteroseintelligence.com/Adult-Vaccine-Access-Coalition) (AVAC)[\[24\]](#fn24)
- [Alliance for a Stronger FDA](https://www.whiteroseintelligence.com/Alliance-for-a-Stronger-FDA)[\[25\]](#fn25)
- [Biotechnology Innovation Organization](https://www.whiteroseintelligence.com/Biotechnology-Innovation-Organization) (BIO)[\[26\]](#fn26)
- CIHR Canadian HIV Trials Network[\[27\]](#fn27)
- [Concordia](https://www.whiteroseintelligence.com/Concordia)[\[28\]](#fn28)
- [Global Alliance for Responsible Media](https://www.whiteroseintelligence.com/Global-Alliance-for-Responsible-Media) (GARM)[\[29\]](#fn29)
- [Medical CBRN Defense Consortium](https://www.whiteroseintelligence.com/Medical-CBRN-Defense-Consortium) (MCDC)[\[30\]](#fn30)
- [Pharmaceutical Research and Manufacturers of America](https://www.whiteroseintelligence.com/Pharmaceutical-Research-and-Manufacturers-of-America) (PhRMA)[\[31\]](#fn31)
- [World Economic Forum](https://www.whiteroseintelligence.com/World-Economic-Forum)[\[32\]](#fn32)

Merck has been a tenant at [MaRS Discovery District](https://www.whiteroseintelligence.com/MaRS-Discovery-District).[\[33\]](#fn33) The company has received funding from the [Bill & Melinda Gates Foundation Strategic Investment Fund](https://www.whiteroseintelligence.com/Bill-&-Melinda-Gates-Foundation-Strategic-Investment-Fund).[\[34\]](#fn34)

## Activities

Merck has provided notable funding to:

- [19 to Zero](https://www.whiteroseintelligence.com/19-to-Zero)[\[35\]](#fn35)
- [Alliance for Aging Research](https://www.whiteroseintelligence.com/Alliance-for-Aging-Research)[\[36\]](#fn36)
- [American Red Cross](https://www.whiteroseintelligence.com/American-Red-Cross)[\[37\]](#fn37)
- [BCCDC Foundation for Public Health](https://www.whiteroseintelligence.com/BCCDC-Foundation-for-Public-Health)[\[38\]](#fn38)
- [Canadian Broadcasting Corporation](https://www.whiteroseintelligence.com/Canadian-Broadcasting-Corporation) (CBC)[\[39\]](#fn39)
- [Canadian Paediatric Society](https://www.whiteroseintelligence.com/Canadian-Paediatric-Society) (CPS)[\[40\]](#fn40)
- [Canadian Public Health Association](https://www.whiteroseintelligence.com/Canadian-Public-Health-Association) (CPHA)[\[40:1\]](#fn40)
- [CDC Foundation](https://www.whiteroseintelligence.com/CDC-Foundation)[\[41\]](#fn41)
- [COVID-19 Solidarity Response Fund](https://www.whiteroseintelligence.com/COVID-19-Solidarity-Response-Fund)[\[42\]](#fn42)
- [COVID-19 Therapeutics Accelerator](https://www.whiteroseintelligence.com/COVID-19-Therapeutics-Accelerator)[\[6:1\]](#fn6)
- [Democratic Leadership Council](https://www.whiteroseintelligence.com/Democratic-Leadership-Council) (DLC)[\[43\]](#fn43)
- [Global Liver Institute](https://www.whiteroseintelligence.com/Global-Liver-Institute) (GLI)[\[44\]](#fn44)
- [Hepatitis B Foundation](https://www.whiteroseintelligence.com/Hepatitis-B-Foundation)[\[45\]](#fn45)
- [Hudson Institute](https://www.whiteroseintelligence.com/Hudson-Institute)[\[46\]](#fn46)
- Peter McCullough[\[47\]](#fn47)
- [PhRMA Foundation](https://www.whiteroseintelligence.com/PhRMA-Foundation)[\[48\]](#fn48)
- Senate Majority PAC[\[49\]](#fn49)
- [United Nations Foundation](https://www.whiteroseintelligence.com/United-Nations-Foundation)[\[50\]](#fn50)
- [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) (WHO)[\[51\]](#fn51)
- [World Resources Institute](https://www.whiteroseintelligence.com/World-Resources-Institute) (WRI)[\[52\]](#fn52)

## External links

- [Campfire Wiki](https://www.campfire.wiki/doku.php?id=pharmaceutical%5Fcompanies:merck)
- [Powerbase](https://powerbase.info/index.php/Merck%5Fand%5FCo.%5FInc.)
- [Sourcewatch](https://www.sourcewatch.org/index.php?title=Merck)
- [Wikipedia](https://en.wikipedia.org/wiki/Merck%5F%26%5FCo.)
- [Wikispooks](https://wikispooks.com/wiki/Merck)

---

1. Moody, M., & Herrmann, J. (2022, March 1). *Dr. Julie L. Gerberding to Retire from Merck.* Merck. <https://web.archive.org/web/20240706000359/https://www.merck.com/news/dr-julie-l-gerberding-to-retire-from-merck/> [↩︎](#fnref1) [↩︎](#fnref1:1)
2. *The Trusted Provider of Medical Information since 1899.* Merck Manuals. Retrieved January 18, 2022, from <https://archive.ph/nYPYj> [↩︎](#fnref2)
3. Bank, D., & Buckman, R. (2002, May 17). *Gates Foundation buys stakes in drug makers.* Wall Street Journal. <https://archive.ph/XP9QA> [↩︎](#fnref3)
4. *Merck, Gates Foundation Give $60 Million to Fight HIV/AIDS in Botswana.* (2010, August 25). Philanthropy News Digest; Candid. <http://archive.today/2023.06.21-180752/https://philanthropynewsdigest.org/news/merck-gates-foundation-give-60-million-to-fight-hiv-aids-in-botswana> [↩︎](#fnref4)
5. Eisele, P., & Ronaldo, C. (2016, June 29). *Merck and Moderna Announce Strategic Collaboration to Advance Novel mRNA-Based Personalized Cancer Vaccines with KEYTRUDA® (pembrolizumab) for the Treatment of Multiple Types of Cancer.* Moderna. <https://web.archive.org/web/20170405190328/https://www.modernatx.com/newsroom/press-releases/merck-and-moderna-announce-strategic-collaboration-advance-novel-mrna-based> [↩︎](#fnref5)
6. Staines, R. (2020, March 26). *Pharma giants including Novartis collaborate on COVID-19 therapies.* Pharmaphorum. <http://archive.today/2022.01.18-165943/https://pharmaphorum.com/news/collaborate-covid19-therapies/> [↩︎](#fnref6) [↩︎](#fnref6:1)
7. *MyID launches partnership with Merck & Co Inc. for KEYTRUDA.* (2021, January 20). St George News. <http://archive.today/2023.07.18-183154/https://www.stgeorgeutah.com/news/archive/announcements/myid-launches-partnership-with-merck-co-inc-for-keytruda/> [↩︎](#fnref7)
8. *Home.* This Is Our Shot Canada. Retrieved July 14, 2023, from <https://web.archive.org/web/20230714200256/https://thisisourshot.ca/> [↩︎](#fnref8)
9. *“This is Our Shot” Rallies Canadians to Get Vaccinated Against COVID-19.* (2021, April 28). This Is Our Shot Canada. <https://web.archive.org/web/20230714200244/https://thisisourshot.ca/this-is-our-shot-rallies-canadians-to-get-vaccinated-against-covid-19/> [↩︎](#fnref9)
10. Moody, M., Ryan, P., Dannenbaum, P., Kruper, R., & Carvalho, C. (2021, October 1). *Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study.* Merck. Retrieved December 5, 2021, from <https://archive.ph/Ov4Cg> [↩︎](#fnref10)
11. Halford, B., Howes, L., & Satyanarayana, M. (2021, October 1). *Molnupiravir reduces risk of hospitalization and death in patients with mild to moderate COVID-19.* Chemical & Engineering News; American Chemical Society. <https://archive.ph/8sJfE> [↩︎](#fnref11)
12. *Annual Convention.* National Community Pharmacists Association. Retrieved October 2, 2021, from <https://web.archive.org/web/20211002000616/https://ncpa.org/annual-convention> [↩︎](#fnref12)
13. Lee, J. (2021, November 30). *FDA advisers recommend Merck’s COVID-19 pill in close vote.* MarketWatch. <https://ghostarchive.org/archive/X40X1> [↩︎](#fnref13)
14. Kilgore, T. (2021, December 3). *Merck to supply Government of Canada with up to 1 million courses molnupiravir, its COVID-19 pill.* MarketWatch. Retrieved December 5, 2021, from <http://archive.today/2021.12.06-015701/https://www.marketwatch.com/story/merck-to-supply-government-of-canada-with-up-to-1-million-courses-molnupiravir-its-covid-19-pill-2021-12-03> [↩︎](#fnref14)
15. Moody, M. (2022, January 18). *Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine.* Merck. <https://archive.ph/gpZRy> [↩︎](#fnref15)
16. *William M. Daley Named Chairman Of The Midwest Of JPMorgan Chase.* (2004, May 17). JPMorgan Chase. <https://web.archive.org/web/20240706004914/https://jpmorganchaseco.gcs-web.com/news-releases/news-release-details/william-m-daley-named-chairman-midwest-jpmorgan-chase> [↩︎](#fnref16)
17. *Richard C. Henriques.* Arbutus BioPharma. Retrieved September 26, 2021, from <https://web.archive.org/web/20210926102848/https://investor.arbutusbio.com/board-directors/richard-c-henriques> [↩︎](#fnref17)
18. *Fernando Pons.* European Bank for Reconstruction and Development. Retrieved July 6, 2024, from <https://web.archive.org/web/20240706000029/https://www.ebrd.com/executive-committee/fernando-pons.html> [↩︎](#fnref18)
19. *Walter Strapps: Positions, Relations and Network.* MarketScreener. Retrieved July 6, 2024, from <https://web.archive.org/web/20240706030556/https://uk.marketscreener.com/insider/WALTER-STRAPPS-A37E7P/> [↩︎](#fnref19)
20. *GIS Expert Princess Therese of Liechtenstein.* (2022, January 26). Geopolitical Intelligence Services. <https://web.archive.org/web/20240407012448/https://www.gisreportsonline.com/e/liechtenstein-therese-of/> [↩︎](#fnref20)
21. *Current Organizational Members.* AcademyHealth. Retrieved May 8, 2022, from <https://archive.ph/CjV83> [↩︎](#fnref21)
22. *ACTIV.* National Institutes of Health (NIH). Retrieved April 1, 2022, from <http://archive.today/2022.01.11-042823/https://www.nih.gov/research-training/medical-research-initiatives/activ> [↩︎](#fnref22)
23. *Member Logos.* Ad Standards. Retrieved September 17, 2021, from <https://web.archive.org/web/20210917052119/https://adstandards.ca/about/membership/member-logos/> [↩︎](#fnref23)
24. *AVAC Member Organizations.* (2021). Adult Vaccine Access Coalition. <http://archive.today/2022.07.08-060340/https://adultvaccinesnow.org/our-membership/avac-member-organizations/> [↩︎](#fnref24)
25. *List of Members.* (2022, March 4). Alliance for a Stronger FDA. <http://archive.today/2022.07.08-045902/https://www.strengthenfda.org/members> [↩︎](#fnref25)
26. *BIO Member Directory.* Biotechnology Innovation Organization. Retrieved September 30, 2022, from <https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory> [↩︎](#fnref26)
27. *Partners*. CIHR Canadian HIV Trials Network. Retrieved February 2, 2023, from <https://web.archive.org/web/20230202063247/https://www.hivnet.ubc.ca/partners/> [↩︎](#fnref27)
28. *Meet Our Partners.* Concordia. Retrieved February 14, 2024, from <http://archive.today/2024.02.14-062904/https://www.concordia.net/meet-our-partners/> [↩︎](#fnref28)
29. *Members & Governance.* World Federation of Advertisers. Retrieved December 2, 2023, from <https://web.archive.org/web/20231202141727/https://wfanet.org/leadership/garm/members-governance> [↩︎](#fnref29)
30. *Current Members.* MCDC. Retrieved January 3, 2023, from <http://archive.today/2023.01.03-195328/https://www.medcbrn.org/current-members/> [↩︎](#fnref30)
31. *About.* PhRMA. Retrieved September 14, 2023, from <https://web.archive.org/web/20230914221250/https://phrma.org/About> [↩︎](#fnref31)
32. *Merck.* World Economic Forum. Retrieved February 10, 2022, from <https://archive.ph/a7J76> [↩︎](#fnref32)
33. Treurnicht, I., & Nixon, G. (2014, December 9). *2012 MaRS Annual Report.* Issuu; MaRS. <https://issuu.com/derekaubichon/docs/mar-anr6786%5F2012%5Fannual%5Freport%5Felec/1> [↩︎](#fnref33)
34. *Portfolio - Page 2.* Bill & Melinda Gates Foundation Strategic Innovation Fund. Retrieved September 27, 2023, from <https://web.archive.org/web/20230927091305/https://sif.gatesfoundation.org/portfolio/?fwp%5Fpaged=2&fwp%5Fper%5Fpage=30> [↩︎](#fnref34)
35. *Who we are.* (2021, May 12). 19 to Zero. <https://web.archive.org/web/20210512021256/https://www.19tozero.ca/who-we-are> [↩︎](#fnref35)
36. *How We’re Funded.* (2022). Alliance for Aging Research. <https://web.archive.org/web/20220715161317/https://www.agingresearch.org/about-us/how-were-funded/> [↩︎](#fnref36)
37. *Annual Disaster Giving Program (ADGP) and Disaster Responder Program.* American Red Cross. Retrieved November 15, 2022, from [http://archive.today/2022.11.15-233416/https://www.redcross.org/donations/companies-and-foundations/adgp-disaster-responder-program.html↩︎](http://archive.today/2022.11.15-233416/https://www.redcross.org/donations/companies-and-foundations/adgp-disaster-responder-program.html%E2%86%A9%EF%B8%8E) [↩︎](#fnref37)
38. *Our Public Health Heroes.* BCCDC Foundation for Public Health. Retrieved July 25, 2021, from <https://web.archive.org/web/20210725052518/https://bccdcfoundation.org/our-donors/> [↩︎](#fnref38)
39. *Final Release Package A-2023-00059 CBC, Advertising Companies.* CBC/Radio-Canada. Retrieved October 1, 2023, from <https://archive.org/details/final-release-package-a-2023-00059-cbc-advertising-companies> [↩︎](#fnref39)
40. Pekeles, G. S. *Outfront: Annual Report 2007-2008.* Canadian Paediatric Society. Retrieved June 26, 2023, from <https://web.archive.org/web/20230604214219/https://cps.ca/uploads/publications/AnnualReport07-08-1.pdf> [↩︎](#fnref40) [↩︎](#fnref40:1)
41. Lenzer, J. (2015). Centers for Disease Control and Prevention: protecting the private good? *BMJ, 350*(may15 3), h2362–h2362\. <https://doi.org/10.1136/bmj.h2362> [↩︎](#fnref41)
42. *Supporters of the COVID-19 Solidarity Response Fund for WHO.* (2020, May 26). WHO Foundation. <https://web.archive.org/web/20200526183201/https://covid19responsefund.org/en/supporters> [↩︎](#fnref42)
43. Turque, B. (2000, August 20). *The Soul And The Steel.* Newsweek. <http://archive.today/2020.08.06-155924/https://www.newsweek.com/soul-and-steel-158731> [↩︎](#fnref43)
44. *Who We Are.* Global Liver Institute. Retrieved July 10, 2023, from <https://web.archive.org/web/20230710042334/https://globalliver.org/who-we-are/> [↩︎](#fnref44)
45. *Leading the Way to 2030: 2018 Annual Report.* Hepatitis B Foundation. Retrieved March 14, 2023, from <https://web.archive.org/web/20230314121320/https://www.hepb.org/assets/Uploads/HepB-2018-Annual-Report-FINAL.pdf> [↩︎](#fnref45)
46. Stern, W. P., & London, H. I. (2003, January 1). *2002 Hudson Institute Annual Report.* Hudson Institute. <https://web.archive.org/web/20130923185459/http://www.hudson.org/files/publications/Hudson2002AnnualReportFinal.pdf> [↩︎](#fnref46)
47. *Peter Andrew McCullough.* Open Payments Data - CMS. Retrieved February 2, 2024, from <https://openpaymentsdata.cms.gov/physician/335114> [↩︎](#fnref47)
48. Plump, A., & Miller, A. M. (2022, June). *2021 Annual Report.* PhRMA Foundation. <https://web.archive.org/web/20230219205032/https://www.phrmafoundation.org/wp-content/uploads/2022/06/PhRMAFoundation%5F2021AnnualReport.pdf> [↩︎](#fnref48)
49. *Merck & Co.* OpenSecrets. Retrieved July 5, 2024, from <https://www.opensecrets.org/orgs/merck-co/recipients?id=D000000275> [↩︎](#fnref49)
50. *More of Our Partners.* United Nations Foundation. Retrieved October 1, 2023, from <https://web.archive.org/web/20231001222831/https://unfoundation.org/who-we-are/our-partners/more-of-our-partners-2/> [↩︎](#fnref50)
51. *Voluntary contributions by fund and by contributor, 2021.* (2022). World Health Organization. <https://web.archive.org/web/20220516042059/https://apps.who.int/gb/ebwha/pdf%5Ffiles/WHA75/A75%5FINF5-en.pdf> [↩︎](#fnref51)
52. Dasgupta, A. (2022). *From Commitments to Action: Annual Report 2021* (pp. 38–47). World Resources Institute. <https://web.archive.org/web/20220730190344/https://files.wri.org/d8/s3fs-public/2022-04/wri-annual-report-2021.pdf> [↩︎](#fnref52)